Driehaus US Micro Cap Equity Fund

Latest Nav
Date of Latest NAV
13 January 2021
Russell Micro Cap Growth TR USD
US Small-Cap Equity
Investment Style
Small Growth
Fund Size


The investment objective of the Fund is to achieve long-term capital growth.

The Fund’s Sub-Investment Manager, Driehaus Capital Management LLC, is a privately-held boutique asset management firm located in Chicago, USA. The firm was founded in 1982 and has USD 10 billion of assets under management.

The strategy primarily invests in US micro-capitalization companies with good growth potential and with a market capitalization within the same range at the time of investment as those included in the Russell Microcap® Growth Index. Investment decisions are based on the belief that fundamentally strong companies are more likely to generate superior earnings growth on a sustained basis and are more likely to experience positive earnings revisions. Investment decisions involve evaluating a company’s competitive position, industry dynamics, identifying potential growth catalysts and assessing the financial position of the relevant company.

Key stats

Sub-Investment Manager

Driehaus Capital Management

Investment Team Location

Chicago, Illinois, USA


Active with reference to a benchmark


Russell Micro Cap Growth TR USD

Fund Size


Fund Launch

07 December 2016

Share Class Launch

08 September 2017

Share Class CCY


Management Fee


Min. Investment


Fund Type





BBH Trustee Services (Ireland) Ltd


Grant Thornton


Daily by 14:00 Irish Time





Risk Management

Lower RiskHigher Risk


Past performance is no guide to future performance and the value of investment and income from them can fall as well as rise.

Growth Of Investment



Driehaus US Micro Cap Equity Fund Q4 2020 Webcast

Top Ten Holdings

As of 30 November 2020
NameSectorCountryWeight %
1Sitime Corp Ordinary SharesInformation TechnologyUnited States2.1
2Growgeneration CorpConsumer DiscretionaryUnited States2.1
3Natera IncHealth CareUnited States1.9
4Inspire Medical Systems IncHealth CareUnited States1.8
5Magnite IncConsumer DiscretionaryUnited States1.8
6Springworks Therapeutics Inc Ordinary SharesHealth CareUnited States1.7
7Twist Bioscience CorpHealth CareUnited States1.6
8Celsius Holdings IncConsumer StaplesUnited States1.6
9Chart Industries IncIndustrialsUnited States1.4
10Ultra Clean Holdings IncInformation TechnologyUnited States1.4


Heptagon Capital Limited, Heptagon Capital LLP and its Partners disclaim any and all liability relating to these materials, including, without limitation, any express or implied representations or warranties for statements or errors contained in, and omissions from, these materials. Certain assumptions have been made, and/or parameters set, in the preparation of these materials which have resulted in the returns detailed herein, and no representation or warranty is made that any returns indicated will be achieved. Changes to assumptions or parameters may have a material impact on the returns detailed. This document should not be considered an offer to buy or sell investments. Heptagon Capital Limited has issued this communication as investment manager for Heptagon Fund PLC, and is licenced to conduct investment services by the Malta Financial Services Authority.

Heptagon Capital LLP, acting as Distributor, is authorised and regulated in the UK by the Financial Conduct Authority.

Representative and Paying Agent in Switzerland is Société Générale, Paris, Zurich branch, Talacker 50, PO Box 1928, 8021 Zurich, Switzerland. The prospectus, the key investor information document, the Articles and the annual and semi-annual reports are available free of charge from the Swiss representative.

The results given herein are based solely upon historical fund performance as gathered and supplied by Morningstar. That past performance has not been independently verified by either Heptagon Capital Limited or Heptagon Capital LLP. It is not intended to predict or depict the future performance of any investment. Past performance is not necessarily indicative of future returns.

The information contained herein is provided for informational purposes only, is not complete, and does not contain certain material information about the funds, including important disclosures and risk factors associated with an investment in the funds. Before making an investment in any fund, prospective investors are advised to thoroughly and carefully review the fund’s private placement memorandum with their financial, legal and tax advisors to determine whether an investment is suitable for them. An investment in these funds is not suitable for all investors.

London Stock Exchange Group plc and its group undertakings (collectively, the “LSE Group”). © LSE Group 2020. FTSE Russell is a trading name of certain of the LSE Group companies. Russell® is a trade mark of the relevant LSE Group companies and is used by any other LSE Group company under license. All rights in the FTSE Russell indexes or data vest in the relevant LSE Group company which owns the index or the data. Neither LSE Group nor its licensors accept any liability for any errors or omissions in the indexes or data and no party may rely on any indexes or data contained in this communication. No further distribution of data from the LSE Group is permitted without the relevant LSE Group company’s express written consent. The LSE Group does not promote, sponsor or endorse the content of this communication.